Prevalence of anti-HCV antibodies in chronic liver disease in the Czech Republic

被引：2
|
作者：
Stransky, J
Horejsova, M
Chlumska, A
Honzakova, E
Vandasova, J
Nemecek, V
机构：
[1] CHARLES UNIV,FAC MED 3,INTERNAL CLIN 2,PRAGUE 10034 10,CZECH REPUBLIC
[2] CHARLES UNIV,FAC MED 1,PATHOL INST 2,PRAGUE 12808 2,CZECH REPUBLIC
[3] BULOVKA FAC HOSP,REG HYG STN,DEPT VIROL,PRAGUE 18000 8,CZECH REPUBLIC
[4] NATL INST HLTH,PRAGUE 10034 10,CZECH REPUBLIC
来源：
INFECTION | 1997年 / 25卷 / 01期
关键词：
D O I：
10.1007/BF02113511
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [31] PREVALENCE OF ANTI-HCV IN PATIENTS WITH VARIOUS LIVER-DISEASES IN KOREA
    YOO, JY
    SHIN, HK
    PARK, CK
    CHUNG, KW
    SUN, HS
    CHUNG, WK
    DIBISCEGLIE, AM
    WAGGONER, JJ
    HOOFNAGLE, JH
    HEPATOLOGY, 1990, 12 (04) : 975 - 975
  • [32] THE PRESENCE OF ANTI-HCV ANTIBODIES IN THE SERUM OF PATIENTS WITH CHRONIC ACTIVE HEPATITIS AND ANTINUCLEAR ANTIBODIES
    ROGET, M
    BUTI, M
    ESTEBAN, JI
    ESTEBAN, R
    GUARDIA, J
    HEPATOLOGY, 1990, 11 (02) : 333 - 334
  • [33] Prevalence of anti-HCV antibodies in the personnel of the Antoine-Beclere Hospital.
    Maillard, MF
    Poynard, T
    Dubreuil, P
    Agostini, H
    Hautecoeur, B
    Pillot, J
    Chaput, JC
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1996, 20 (12): : 1053 - 1057
  • [34] Pathogenetic significance of neutralizing anti-HCV antibodies in acute and chronic hepatitis C virus (HCV) infection of chimpanzees treated with hyperimmune anti-HCV (Civacir™)
    Krawczynski, K
    Bartosch, B
    Meunier, JC
    Basham, L
    Culver, D
    Lavillette, D
    Kamili, S
    Cosset, FL
    Fattom, A
    HEPATOLOGY, 2005, 42 (04) : 277A - 277A
  • [35] Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco
    Sekkat, Souad
    Kamal, Nabiha
    Benali, Bennaceur
    Fellah, Hassan
    Amazian, Kamelia
    Bourquia, Amal
    El Kholti, Abdeljalil
    Benslimane, Abdellah
    NEPHROLOGIE & THERAPEUTIQUE, 2008, 4 (02): : 105 - 110
  • [36] Prevalence of anti-HCV antibodies in the congolese population: A study on 985 blood donors
    Elenga, JPO
    Atanda, H
    Koffi, G
    Sangare, A
    Lomani, BLD
    MEDECINE ET MALADIES INFECTIEUSES, 1998, 28 (10): : 673 - +
  • [37] Clinical manifestations of HBsAg and anti-HCV negative chronic liver disease in Nagasaki Prefecture, Japan
    Omagari, K
    Komatsu, K
    Kato, Y
    Nakata, K
    Kusumoto, Y
    Mori, I
    Furukawa, R
    Tanioka, H
    Tajima, H
    Koga, M
    Yano, M
    INTERNAL MEDICINE, 1996, 35 (08) : 600 - 604
  • [38] INTERFERON THERAPY OF CRYPTOGENIC CHRONIC ACTIVE LIVER-DISEASE AND ITS RELATIONSHIP TO ANTI-HCV
    DIODATI, G
    BONETTI, P
    TAGGER, A
    ALBERTI, A
    REALDI, G
    RUOL, A
    ARCHIVES OF VIROLOGY, 1992, : 299 - 303
  • [39] PREVALENCE OF ANTI-HCV ANTIBODIES AND HCV-RNA IN AN ITALIAN ADULT GENERAL-POPULATION SAMPLE
    ATTILI, AF
    RAPICETTA, M
    MELE, A
    DESANTIS, A
    CHIONNE, P
    CRISTIANO, K
    SPADA, E
    GIULIANI, E
    GOFFREDO, F
    HEPATOLOGY, 1992, 16 (02) : 514 - 514
  • [40] RELATION BETWEEN THE PRESENCE OF HCV-RNA IN SERUM, LIVER AND PBMC AND THE ACTIVITY OF LIVER-DISEASE IN ANTI-HCV CHRONIC CARRIERS
    NAVAS, S
    CASTILLO, I
    ORTEGA, E
    MARRIOTT, E
    BOSCH, O
    BARTOLOME, J
    CARRENO, V
    HEPATOLOGY, 1992, 16 (04) : A215 - A215
12345